References
- Koob GF, Volkow ND. Neurocircuitry of addiction. Neuropsychopharmacology 2010; 35(1):217–38.
- Calcaterra S, Glanz J, Binswanger IA. National trends in pharmaceutical opioid related overdose deaths compared to other substance related overdose deaths: 1999–2009. Drug Alcohol Depend 2013; 131(3):263–70.
- Stein MD, Cioe P, Friedmann PD. Buprenorphine retention in primary care. J Gen Intern Med 2005; 20(11):1038–41.
- Lee JD, Grossman E, DiRocco D, et al. Home buprenorphine/naloxone induction in primary care. J Gen Intern Med 2009; 24(2):226–32.
- Lee JD, Vocci F, Fiellin DA. Unobserved “home” induction onto buprenorphine. J Addict Med 2014; 8(5):299–308.
- Nosyk B, Anglin MD, Brissette S, et al. A call for evidence-based medical treatment of opioid dependence in the United States and Canada. Health Affairs 2013; 32(8):1462–9.
- Hansen HB, Siegel CE, Case BG, et al. Variation in use of buprenorphine and methadone treatment by racial, ethnic, and income characteristics of residential social areas in New York City. J Behav Health Services Res 2013; 40(3):367–77.
- Egan JE, Casadonte P, Gartenmann T, et al. The Physician Clinical Support System-Buprenorphine (PCSS-B): a novel project to expand/improve buprenorphine treatment. J Gen Intern Med 2010; 25(9):936–41.
- Hutchinson E, Catlin M, Andrilla CH, et al. Barriers to primary care physicians prescribing buprenorphine. Annals Family Med 2014; 12(2):128–33.
- Walley AY, Alperen JK, Cheng DM, et al. Office-based management of opioid dependence with buprenorphine: clinical practices and barriers. J Gen Intern Med 2008; 23(9):1393–8.
- Whitley SD, Sohler NL, Kunins HV, et al. Factors associated with complicated buprenorphine inductions. J Substance Abuse Treat 2010; 39(1):51–7.
- Fiellin D, Pantalon M, Schottenfeld R, et al. Manual for standard medical management of opioid dependence with buprenorphine. Yale University, New Haven, CT, 1999.
- Muench F, Weiss RA, Kuerbis A, et al. Developing a theory driven text messaging intervention for addiction care with user driven content. Psychol Addict Behav 2013; 27(1):315–21.
- Cole-Lewis H, Kershaw T. Text messaging as a tool for behavior change in disease prevention and management. Epidemiologic Reviews 2010; 32(1):56–69.
- Horvath T, Azman H, Kennedy GE, et al. Mobile phone text messaging for promoting adherence to antiretroviral therapy in patients with HIV infection. The Cochrane Database Systematic Rev 2012; 3:CD009756.
- Car J, Gurol-Urganci I, de Jongh T, et al. Mobile phone messaging reminders for attendance at healthcare appointments. The Cochrane Database Systematic Rev 2012; 7:CD007458.
- Whittaker R, McRobbie H, Bullen C, et al. Mobile phone-based interventions for smoking cessation. The Cochrane Database Systematic Rev 2012; 11:CD006611.
- Litvin EB, Abrantes AM, Brown RA. Computer and mobile technology-based interventions for substance use disorders: an organizing framework. Addict Behav 2013; 38(3):1747–56.
- Tofighi B, McNeely J, Muench F, et al. Mobile phone messaging for illicit drug and alcohol dependence: a review of the literature 2015; in submission.
- Tofighi B, Buirkle E, McNeely J, et al. Mobile phone use patterns and preferences in office-based buprenorphine patients. J Addict Med 2015;.9(3):217–23.
- McClure EA, Acquavita SP, Harding E, et al. Utilization of communication technology by patients enrolled in substance abuse treatment. Drug Alcohol Depend 2013; 129(1–2):145–50.
- Muench F, Weiss RA, Kuerbis A, et al. Developing a theory driven text messaging intervention for addiction care with user driven content. Psychol Addict Behav 2013; 27(1):315.
- Muench F, Adams MB, McKay JR, et al. Acceptability of mobile messaging in medicated assisted treatment programs. Meeting of the Association for Behavioral and Cognitive Therapists 2012, Washington, DC.
- Lee JD, Grossman E, Truncali A, et al. Buprenorphine-naloxone maintenance following release from jail. Subst Abuse 2012; 33(1):40–7.
- Fox S DM. Mobile Health 2012. Washington, DC: Pew Internet & American Life Project; 2012. http://www.pewinternet.org/∼/media//Files/Reports/2012/PIP_MobileHealth2012_FINAL.pdf.2012 (accessed March 21, 2015).
- Tofighi B, Williams AR, Biary R, et al. Outcomes among buprenorphine-naloxone primary care patients after hurricane Sandy. Addict Sci Clin Practice 2014; 9(3): 3–4.
- Miller WR, Enhancing motivation for change in substance abuse treatment, Vol. 35. Diane Publishing, Rockville, MD, 1999.
- Harris PA, Taylor R, Thielke R, et al. Research electronic data capture (REDCap)—a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Informatics 2009; 42(2):377–81.
- Hansen HB, Siegel CE, Case BG, et al. Variation in use of buprenorphine and methadone treatment by racial, ethnic, and income characteristics of residential social areas in New York City. J Behav Health Services Res 2013; 40(3):367–77.
- Eyrich-Garg KM. Mobile phone technology: a new paradigm for the prevention, treatment, and research of the non-sheltered “street” homeless? J Urban Health 2010; 87(3):365–80.
- Laudet AB, Morgen K, White WL. The role of social supports, spirituality, religiousness, life meaning and affiliation with 12-step fellowships in quality of life satisfaction among individuals in recovery from alcohol and drug problems. Alcoholism Treat Quart 2006; 24(1–2):33–73.
- Stevens E, Jason LA, Ram D, et al. Investigating social support and network relationships in substance use disorder recovery. Subst Abuse 2015; 36: 396–99.
- Krishna S, Boren SA. Diabetes self-management care via cell phone: a systematic review. J Diabetes Sci Tech 2008; 2(3):509–17.
- Prochaska JO, Velicer WF. The transtheoretical model of health behavior change. Am J Health Promotion 1997; 12(1):38–48.
- Prochaska JO, DiClemente CC. Self change processes, self efficacy, and decisional balance across five stages of smoking cessation. Prog Clin Biol Research 1984; 156:131–40.
- Goldzweig CL, Towfigh A, Maglione M, et al. Costs and benefits of health information technology: new trends from the literature. Health Affairs 2009; 28(2):w282–93.